Resultados de la búsqueda 301-310 of 10131 for Anaphylactic shock

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  6. Choque cardiógeno - Síntomas y causas - Mayo Clinic

    Cardiogenic shock. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/cardiogenic-shock. Accessed Dec. 28, 2020. Reyentovich ...

  7. Alergias a los medicamentos - Síntomas y causas - Mayo Clinic

    Allergy, hypersensitivity and anaphylaxis. In: Rosen's Emergency Medicine: Concepts and Clinical Practice. 10th ed. Philadelphia, Pa.: Elsevier; 2023. https ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...